V3V Ventures Invests in U2U Network and CrossCurve by EYWA to Drive Innovation in Blockchain and DeFi
August 26, 2024 13:03 ET
|
V3V Ventures
Singapore, Singapore, Aug. 27, 2024 (GLOBE NEWSWIRE) -- V3V Ventures (V3V.com), a Singapore-based venture capital firm, announced significant investments in the seed round of two cutting-edge...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
August 22, 2024 17:10 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In American Airlines To Contact Him Directly To Discuss Their...
Ranchero Enters Into a Letter of Intent to Sell Mexican Subsidiary, and Related Party Loan
August 21, 2024 07:00 ET
|
Ranchero Gold Corp.
Ranchero Gold Corp. has entered into a letter of intent to sell its wholly-owned subsidiary.
PanOmiQ Set’s New Benchmark with 100% Accuracy in Whole Genome Sequencing Testing
August 20, 2024 09:48 ET
|
BioAro
BioAro's PanOmiQ achieves 100% accuracy in Whole Genome Sequencing, setting a new benchmark; a 15-day free trial of AI-powered software is now available.
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
August 15, 2024 11:25 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in American Airlines stock or options between January 25, 2024 and May 28, 2024 and would like to discuss your legal rights, call Faruqi &...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
August 08, 2024 11:30 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In American Airlines To Contact Him Directly To Discuss Their...
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results
August 07, 2024 09:15 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
August 02, 2024 10:40 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In American Airlines To Contact Him Directly To Discuss Their...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
July 26, 2024 11:15 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in American Airlines stock or options between January 25, 2024 and May 28, 2024 and would like to discuss your legal rights, call Faruqi &...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
July 18, 2024 17:38 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in American Airlines stock or options between January 25, 2024 and May 28, 2024 and would like to discuss your legal rights, call Faruqi &...